Filter News
Area of Research
- (-) Clean Energy (49)
- (-) Neutron Science (45)
- Advanced Manufacturing (3)
- Biology and Environment (21)
- Computational Engineering (1)
- Computer Science (2)
- Energy Frontier Research Centers (1)
- Fusion and Fission (5)
- Isotopes (1)
- Materials (56)
- Materials for Computing (9)
- National Security (14)
- Nuclear Science and Technology (3)
- Quantum information Science (1)
- Supercomputing (46)
News Topics
- (-) Computer Science (13)
- (-) Frontier (2)
- (-) Machine Learning (4)
- (-) Molten Salt (1)
- (-) Nanotechnology (10)
- (-) Neutron Science (40)
- (-) Partnerships (8)
- (-) Polymers (5)
- (-) Sustainable Energy (24)
- 3-D Printing/Advanced Manufacturing (30)
- Advanced Reactors (3)
- Artificial Intelligence (5)
- Big Data (2)
- Bioenergy (15)
- Biology (9)
- Biomedical (7)
- Biotechnology (3)
- Buildings (8)
- Chemical Sciences (10)
- Clean Water (1)
- Climate Change (7)
- Composites (6)
- Coronavirus (9)
- Critical Materials (4)
- Cybersecurity (4)
- Decarbonization (10)
- Energy Storage (26)
- Environment (14)
- Exascale Computing (2)
- Fossil Energy (1)
- Fusion (2)
- Grid (9)
- High-Performance Computing (3)
- Isotopes (1)
- Materials (21)
- Materials Science (23)
- Mercury (1)
- Microscopy (4)
- National Security (5)
- Net Zero (1)
- Nuclear Energy (4)
- Physics (8)
- Quantum Science (4)
- Renewable Energy (1)
- Security (4)
- Simulation (1)
- Space Exploration (1)
- Summit (5)
- Transformational Challenge Reactor (3)
- Transportation (18)
Media Contacts
Researchers at the Department of Energy’s Oak Ridge National Laboratory have received five 2019 R&D 100 Awards, increasing the lab’s total to 221 since the award’s inception in 1963.
Using the Titan supercomputer and the Spallation Neutron Source at the Department of Energy’s Oak Ridge National Laboratory, scientists have created the most accurate 3D model yet of an intrinsically disordered protein, revealing the ensemble of its atomic-level structures.
Quanex Building Products has signed a non-exclusive agreement to license a method to produce insulating material from ORNL. The low-cost material can be used as an additive to increase thermal insulation performance and improve energy efficiency when applied to a variety of building products.
Electro-Active Technologies, Inc., of Knoxville, Tenn., has exclusively licensed two biorefinery technologies invented and patented by the startup’s co-founders while working at the Department of Energy’s Oak Ridge National Laboratory. The technologies work as a system that converts organic waste into renewable hydrogen gas for use as a biofuel.
IDEMIA Identity & Security USA has licensed an advanced optical array developed at Oak Ridge National Laboratory. The portable technology can be used to help identify individuals in challenging outdoor conditions.
Collaborators at the Department of Energy’s Oak Ridge National Laboratory and U.S. universities used neutron scattering and other advanced characterization techniques to study how a prominent catalyst enables the “water-gas shift” reaction to purify and generate hydrogen at industrial scale.
A team of scientists led by Oak Ridge National Laboratory have discovered the specific gene that controls an important symbiotic relationship between plants and soil fungi, and successfully facilitated the symbiosis in a plant that
An ORNL-led team's observation of certain crystalline ice phases challenges accepted theories about super-cooled water and non-crystalline ice. Their findings, reported in the journal Nature, will also lead to better understanding of ice and its various phases found on other planets, moons and elsewhere in space.
OAK RIDGE, Tenn., May 14, 2019—Advanced Research Systems, Inc., has licensed a technology designed to automatically refill liquid helium used in laboratory equipment for low-temperature scientific experiments, which will reduce downtime, recover more helium and increase overall efficiency.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.